Genèse Labs

14

A rose exosome bio-cellulose sheet mask designed for post-treatment recovery Paris, France — 17 November 2025 — Genèse Labs has launched Exo-Mask, a post-treatment sheet mask formulated with rose stem-cell exosomes and salmon DNA (PDRN), extending its portfolio from treatment through to aftercare.• Formulated with rose stem-cell exosomes, 1% salmon DNA (PDRN), NAD⁺, glutathione and hyaluronic acid• Bio-cellular sheet with..

2025-11-17

13

Proluma™ RH Collagen Launch

A skin booster built on recombinant human collagen Type I and III Paris, France — 8 September 2025 — Genèse Labs has launched Proluma™ RH Collagen, a skin booster built on recombinant human collagen Type I and III, extending the Proluma™ brand beyond biostimulators into collagen-based skin quality.• Recombinant human collagen Type I and III produced through bio-fermentation technology• Animal-free ingredient replicating t..

2025-09-08

12

Exoluma™ Exo-PDRN Launch

Dual regeneration technology: French salmon DNA-derived PDRN meets plant-derived exosomes Paris, France — 16 June 2025 — Genèse Labs has launched Exoluma™ Exo-PDRN, a skin booster combining salmon sperm DNA-derived PDRN with plant-derived exosomes, extending the exosome-based Exoluma™ platform.• Pharmaceutical-grade salmon DNA-derived PDRN manufactured in France by HTL Biotechnology• Dual-regeneration concept: PDRN for st..

2025-06-16

11

RG Body Filler Line-Up Expanded: RG80, RG100 and RG55S

From a single product to a graduated family for non-surgical body contouring Paris, France — 20 May 2025 — Genèse Labs has added RG80, RG100 and the syringe-type RG55S to its RG Body Filler line. Building on RG60®, the company’s first in-house product launched in 2023, practitioners can now select from four formats according to treatment area and volume.• Launch of RG80 (80 ml), RG100 (100 ml) and RG55S (55 ml s..

2025-05-20

10

Réluma HA Filler and Réluma Kiss Launch with KFDA Approval

Premium French hyaluronic acid meets Hexa-Matrix Crosslinking Technology Paris, France — 8 April 2025 — Genèse Labs has launched Réluma, a facial hyaluronic acid filler line built on high-purity HA from HTL Biotechnology, France, together with the lip-dedicated Réluma Kiss, and has obtained KFDA approval for Réluma.• Hyaluronic acid from HTL Biotechnology, France, a world-leading manufacturer of high-purity HA• ..

2025-04-08

9

Proluma™ PLLA Launch and CE Certification

Completing the Proluma™ biostimulator line: PLLA 365 mg for deep structural volume restoration Paris, France — 17 February 2025 — Genèse Labs has launched Proluma™ PLLA 365 mg, an injectable collagen biostimulator, together with CE certification as a Class III medical device — completing a two-formulation Proluma™ line alongside PDLLA 200 mg.• Injectable collagen biostimulator based on poly-L-lactic acid (PLLA) 3..

2025-02-17

8

Exoluma™ Plant & Human Series Launch and CPNP Registration

Nobel-recognised science in skincare: Exoluma™, a next-generation exosome complex solution Paris, France — 30 October 2024 — Genèse Labs has launched the Exoluma™ Plant & Human series — a dual-vial system combining purified exosomes with regenerative ingredients — together with completion of CPNP registration, closing a year in which the company brought four product families to market.• Dual-vial exosome com..

2024-10-30

7

Citrus Bottle™ Launch and CPNP Registration

Citrus Bottle™: a next-generation slimming solution targeting adipocyte metabolism Paris, France — 22 April 2024 — Genèse Labs has launched Citrus Bottle™, a facial and body slimming solution based on adipocyte-metabolism technology, together with completion of its trademark registration and CPNP registration — extending the company’s portfolio into a new area of body contouring.• A facial and body slimming solu..

2024-04-22

6

Proluma™ PDLLA Launch and CE Certification

Next-generation collagen biostimulator: Proluma™ PDLLA 200 mg Paris, France — 14 February 2024 — Genèse Labs has launched Proluma™ PDLLA, an injectable collagen stimulator built on polymer technology developed at the company’s French headquarters, together with completion of the Proluma™ trademark registration.• Injectable collagen biostimulator based on Poly-D,L-lactic acid (PDLLA) 200 mg• PLA-family materials ..

2024-02-14

5

Launch of RG60® HA Body Filler

First in-house product RG60® sets a new standard in non-surgical body contouring Paris, France — 25 September 2023 — Genèse Labs has launched RG60® HA Body Filler, the company’s first in-house product, together with completion of the RG60™ trademark registration — an injectable dermal filler developed on French biotechnology and designed to refine body contours and correct volume without surgery.• First in-house..

2023-09-25

4

Partnerships Signed with KOLs and Biotech Laboratories

A collaborative development model built with clinicians and research partners Paris, France — 18 June 2023 — Genèse Labs has entered into formal partnerships with Key Opinion Leaders (KOLs) and biotechnology laboratories to develop its next generation of aesthetic products, involving clinicians directly from the formulation stage rather than only in post-launch evaluation.• Clinicians engaged from the earliest stages of formulation design, not merely po..

2023-06-18

3

Genèse Labs France Established

From distributor to product developer: completing a structural transition Paris, France — 20 March 2023 — Genèse Labs has been re-established as Genèse Labs France, shifting its business model from the distribution of aesthetic products to in-house product development and global brand ownership. From distributor to product developer: completing a structural transition Paris, France — 20 March 2023 — ..

2023-03-20

검색

We value your privacy